Ongoing assessments by the HTA Center of Västra Götaland Region in Sweden as of June 2026

Sweden has several regional HTA units that provide evidence-based assessments to support decision-making at the regional level. In general, HTA recommendations are not mandatory for hospitals to follow. However, they can have a meaningful impact on clinical practice, as healthcare decisions in Sweden are typically evidence-based.

As of June 2026, the HTA Center of Västra Götaland Region is working on six health technology assessments, including the following:

• Radiofrequency ablation as a treatment method for uterine fibroids;
• The health economic benefit of performing an EEG (electroencephalography) examination in all adult patients after a first unprovoked epileptic seizure;
• Radiofrequency therapy for the treatment of long-term nociceptive joint pain;
• Delivery with a low-lying placenta and vaginal birth, and the risk of postpartum hemorrhage;
• sFlt-1 and PlGF testing in the diagnosis of preeclampsia.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.